BamSEC and AlphaSense Join Forces
Learn More

Contineum Therapeutics Inc. – Material Contracts

NASDAQ: CTNM    
Share price (11/4/26): $9.79    
Market cap (11/4/26): $384 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.17
from 10-K 2 pages Contineum Therapeutics, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.16
from 10-K 27 pages Contineum Therapeutics, Inc. 2026 Employment Inducement Equity Incentive Plan (As Adopted on January 23, 2026) Contineum Therapeutics, Inc. 2026 Employment Inducement Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 3 pages Via Email Timothy Watkins, MD Msc WATKINS.TR@GMAIL.com Re: Amendment to Offer Letter Dear Tim
12/34/56
EX-10.1
from 10-Q 5 pages Via Email Timothy Watkins, MD Msc WATKINS.TR@GMAIL.com April 3, 2025
12/34/56
EX-10.1
from 10-Q 9 pages Material contract
12/34/56
EX-10.9
from 10-K 7 pages Pipeline Therapeutics, Inc. 10578 Science Center Drive, Suite 200 San Diego, Ca 92121 December 12, 2019
12/34/56
EX-10.3
from 10-Q ~5 pages Contineum Therapeutics, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.2
from 10-Q 3 pages Material contract
12/34/56
EX-10.2
from 8-K ~5 pages Mutual Arbitration Agreement
12/34/56
EX-10.1
from 8-K 3 pages Contineum Therapeutics, Inc. Executive Severance Plan
12/34/56
EX-10.7
from S-1/A 6 pages Pipeline Therapeutics, Inc. 10578 Science Center Drive, Suite 200 San Diego, Ca 92121 August 20, 2020
12/34/56
EX-10.6
from S-1/A 8 pages Pipeline Therapeutics, Inc. 10578 Science Center Drive, Suite 200 San Diego, California 92121 March 9, 2018
12/34/56
EX-10.5
from S-1/A 7 pages Pipeline Therapeutics, Inc. 10578 Science Center Drive Suite 200 San Diego, Ca 92121 August 14, 2018
12/34/56
EX-10.4
from S-1/A 13 pages Contineum Therapeutics, Inc. 2024 Employee Stock Purchase Plan (As Adopted on March 27, 2024) Contineum Therapeutics, Inc. 2024 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 27 pages Contineum Therapeutics, Inc. 2024 Equity Incentive Plan (As Adopted on March 27, 2024) Contineum Therapeutics, Inc. 2024 Equity Incentive Plan
12/34/56
EX-10.1
from S-1/A 11 pages [Amended and Restated]1 Indemnity Agreement
12/34/56
EX-10.16
from S-1 107 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential, and Has Been Marked With “[***]” to Indicate Where Omissions Have Been Made
12/34/56
EX-10.13
from S-1 52 pages Lease Agreement
12/34/56
EX-10.12
from S-1 4 pages Agreement for Termination of Lease and Voluntary Surrender of Premises
12/34/56
EX-10.11
from S-1 8 pages Third Amendment to Lease
12/34/56